Why does the COVID-19 virus make some people sicker than others? For years, scientists have looked to a critical piece of ...
Wexford-based biopharmaceutical company Coeptis Therapeutics Holdings Inc. is diversifying itself, launching a new division, ...
After years of debilitating bouts of fatigue, Beth VanOrden finally thought she had an answer to her problems in 2016 when ...
Investors in Padlock Therapeutics have accused Bristol Myers Squibb of reneging on payments of up to $450 million negotiated ...
More than two billion people around the world are infected with a brain parasite called Toxoplasma gondii. This parasite is ...
Argenx SE (NASDAQ:ARGX) is a biotechnology company focused on autoimmune diseases. The one-month return of Argenx SE ...
In Philadelphia’s Norris Square neighborhood, Shannon Turner, a celebrated singer, vocal coach, and founder of the band ...
Cells in the immune system don't always fight; they often rest and wait for threats, like viruses or bacteria.
Cells in the immune system don't always fight; they often rest and wait for threats, like viruses or bacteria. When such ...
Cyrus Biotechnology announces potent in vivo redosability of an engineered IdeS protease for IgG-driven autoimmune disease.
Autoimmune diseases arise when the immune system mistakenly targets and damages the body’s cells and tissues as though they were foreign invaders. This widespread category of illnesses, such as ...
By far, the largest acquisition of 2024 was Novo Holdings' yet-to-be-closed buyout of manufacturer Catalent at $16.5 billion.